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Sickle erythrocytes exhibit decreased deformability and
increased adhesivity, which are due to secondary defects in
the cell membrane. To search for defects, high resolution
polyacrylamide gel electrophoretic techniques in conjunction
with various stains were used to compare the protein
composition of sickle and normal erythrocyte membranes.
Several alterations were detected in sickle membranes,
including an increase in protein 4.1b and the appearance of
a high molecular weight complex. While the mechanism
responsible for these alterations is unclear, the alteration
in 4.1b is not due to proteolysis or adsorption of
cytoplasmic proteins, nor is it associated uniquely with
young erythrocytes or irreversible sickled cells.
Additional quantitative alterations were detected with
crosslinking reagents. It is plausible that these molecular
alterations are a cause of the abnormal deformability and
adhesivity of sickle erythrocytes.
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CHAPTER I
INTRODUCTION
Sickle cell anemia is a hereditary disease which
presents a variety of clinical symptoms, ranging from mild
to very severe conditions. The disease, which predominately
affects Blacks, is very debilitating and often results in
premature death. It is characterized by an abnormal
hemoglobin molecule called Hemoglobin S (HbS) which was
first detected by Pauling et al. (1949). The nature of the
defect was identified by Ingram (1956) as a single point
mutation that gives rise to a single amino acid substitution
of valine for glutamic acid at the six position of the beta
chain in adult hemoglobin. Hemoglobin S polymerizes under
low oxygen tension and as a consequence, the cell changes
from a biconcave disc to a sickle shape.
There are several abnormal properties which exist in
the sickle cell including increased adhesivity, decreased
deformability, and increased intracellular calcium. The
mechanism by which these alterations occur is still unclear.
However, it appears that secondary defects in the sickle
cell membrane are, at least in part, responsible for all of
these abnormal properties. To search for defects, previous
investigations have been directed towards examining the
protein composition of sickle membranes in comparison to
that of normal membranes, but the results of these studies
have been controversial. There have been no comprehensive
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studies on the organization of membrane proteins in the
sickle cell; thus a detailed study employing crosslinking
reagents is warranted.
This research project was designed to (1) search for
differences in protein composition between normal and sickle
membranes employing high resolution polyacrylamide gel
electrophoresis and various stains; (2) search for altered
protein associations in sickle membranes employing a variety
of crosslinking reagents and two-dimensional diagonal gel
electrophoresis; and (3) understand the mechanism by which
these alterations occur.
Characterization of any molecular alterations in the
sickle cell membrane may provide clues regarding the
mechanisms responsible for the cellular aberrations which
exist in sickle cells. A deeper understanding of these
alterations could possibly lead to a therapeutic treatment
for sickle cell anemia.
CHAPTER II
REVIEW OF LITERATURE
Sickle cell anemia is a genetic hemolytic disease
characterized by the abnormal hemoglobin molecule, sickle
hemoglobin (HbS), John Herrick {1910), who reported the
first account of the disease, noted peculiar shaped sickle
cells in the peripheral blood of a Black West Indian
student.
In 1949, Neel and Beet independently demonstrated that
sickle cell anemia is a hereditary disease and that its
inheritance is due to a single autosomal recessive gene.
Therefore, individuals with one gene for sickle cell anemia
are "carriers” and asymptomatic (sickle cell trait).
Individuals homozygous for the mutated gene have the
disease.
Molecular studies of sickle cell anemia began after the
identification of HbS as a defective molecule by Pauling et
al. (1949), who demonstrated a difference in electrophoretic
mobility between normal and sickle hemoglobins and correctly
attributed this phenomenon to a charge modification in the
globin chain. Vernon Ingram (1956) identified the nature of
the primary defect within the HbS molecule using the
fingerprinting technique. The abnormal hemoglobin results
from a single amino acid substitution of valine for glutamic
acid at the sixth position of the beta chain in adult
hemoglobin. As a consequence of this amino acid
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substitution, HbS is insoluble under deoxygenated conditions
due to hydrophobic interactions between HbS molecules
(Murayama, 1966). This results in the formation of long
polymers of HbS which lead to the distortion of the red cell
membrane into an abnormal spiculed shape.
An individual with sickle cell anemia has a number of
clinical problems. One of the symptoms is chronic hemolytic
anemia which is due to the shortened life span of the sickle
erythrocyte and lack of compensating increase in synthesis
of red blood cells (Singer et al., 1948; Callender et al.,
1949). The most prevalent and devastating symptom of the
disease is the "vaso-occlusive crisis." Vaso-occlusion is
the result of obstruction of blood vessels and capillaries
by sickled cells. These painful episodes usually occur in
the joints and other extremities and can prevent oxygen from
reaching organs, thus leading to necrosis. Vaso-occlusive
crisis occurs with varying frequency and duration from one
individual to the next. Other symptoms of the disease are
necrosis of the bone, ulcers, stroke and heart attack.
Sickle cell anemics are also extremely susceptible to
bacterial infections primarily caused by Salmonella and
Pnuemococcus; however, these infections can be combated with
the usual antibiotics.
The blood of the sickle cell anemic consists of a
heterogeneous population of erythrocytes comprised mainly of
irreversible sickled cells (ISCs) and non-irreversible
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sickled cells (non-ISCs). Upon exposure to air (Diggs and
Bibb, 1939) or 95% oxygen (Bertles and Milner, 1968), the
ISC, in contrast to the non-ISC, remains permanently fixed
in its abnormal shape. The ISC is characterized by its
elongated crescent shape in which its length to width ratio
is 2:1 (Diggs and Bibb, 1939; Murphy and Shapiro, 1945; Lux
et al., 1976). ISCs vary in proportion in the circulatory
system of sickle cell anemics from an average of 5% to 50%
(Diggs, 1956; Bertles and Milner, 1968; Sergeant et al.,
1969). It has been proposed that ISCs contribute to vaso-
occlusive crisis. In a rat model, ISCs are preferentially
lodged in capillaries (Klug et al., 1974) but a positive
correlation has not been observed between the percentage of
these cells and the frequency at which the pain crisis
occurs (Diggs, 1956). The difficulties in establishing a
relationship between ISCs and vaso-occlusive crises may be
due to the effect of unknown factors which contribute to
crises, as well as the lack of a more efficient and reliable
method to quantitate the percentage of ISCs (Rodgers et al.,
1985).
Many attempts have been made to provide an effective
treatment to alleviate pain crisis and to inhibit the
polymerization of hemoglobin. Hyperbaric oxygenation,
transfusion and hydration have been ineffective in
preventing or decreasing the duration of vaso-occlusive
crisis (Charache, 1981). Narcotics and sedatives are often
6
used to comfort the patient but this only provides temporary
relief.
Murayama (1966) proposed that hydrophobic interactions
were responsible for the polymerization of deoxygenated HbS.
This finding stimulated studies on possible agents which
could prevent sickling by disrupting hydrophobic bonds.
Urea and cyanate, two of the first antisickling agents
tested, prevent sickling vitro (Cerami and Manning,
1971). However, inorder to prevent sickling iji vivo, they
must be administered in high concentrations which results in
non-specific toxic side effects. The administration of
cyanate extracorporeally has been shown to decrease the
overall frequency of pain crisis (Diederich et al., 1976)
but this procedure is time-consuming and costly.
Extracorporeal treatment systems are currently under
development (Uvelli et al., 1980). Analogs of urea and
cyanate have also been tested but they too appear to be
ineffective. Other therapeutic agents are currently under
investigation in an attempt to provide an effective
treatment without adverse side effects (Asakura et al.,
1980; Berkowitz and Orringer, 1981; Chang et al., 1983; Guis
et al., 1984).
Several cellular alterations have been observed in the
sickle erythrocyte including changes in cell shape,
deformability and adhesivity. These alterations may be
attributed to defects in the membrane which have not been
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defined at the molecular level. These defects could account
for many of the unique properties of the sickle cell. Since
there is no evidence for a second gene mutation in sickle
cells, it is thought that the defects may be secondary ones
arising from the interaction of the cell membrane with
polymerized hemoglobin—a product of the primary defect in
the sickle hemoglobin molecule (Ingram, 1959).
The normal shape of erythrocytes is determined by an
interconnecting network of proteins underlying the cell
membrane (Yu et al., 1973). This network consists primarily
of spectrin, actin, and band 4.1, and is called the membrane
skeleton (formerly called the "cytoskeleton”) (Sheetz,
1979). The membrane skeleton is also responsible for the
mechanical stability and flexibility of the cell (Steck,
1974; Lux, 1979) and the distribution of transmembrane
proteins (Elgsaeter and Branton, 1974; Palek and Liu, 1979).
Red cell deformability can be defined as those
geometric and physical characteristics that permit the cell
to pass through the anatomically restricted regions of the
microcirculation (Bessis and Mohandas, 1975). Cell
deformability is dependent upon internal viscosity (i.e.,
the state and concentration of hemoglobin in solution),
membrane flexibility, and surface to volume ratio (Chien et
al., 1970).
Many techniques for measuring cellular deformability
(e.g., microsieving, raicropipetting and positive pressure
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cellular filtration) have shown that sickle cells are less
deformable (more rigid) than normal cells (La Celle, 1970;
Usami et al., 1975; Lessin et al., 1977). The high
sensitivity of the ektacytometer (a laser diffraction
viscometer) has been useful in determining possible
explanations for the reduced deformability of sickle cells
(Bessis et al., 1982). Studies employing this instrument
showed that both non-ISCs and ISCs (which are more rigid
than the non-ISCs) exhibit decreased deformability even
under high oxygen tensions and that increasing cell water
content restored cell deformability (Clark et al., 1980a,
Clark et al., 1980b; Gulley et al., 1982). These findings
suggest that decreased deformability is at least, in part, a
consequence of cell dehydration.
Sickle cells have a propensity for adhering to vascular
endothelium—an abnormality which does not require
deformation or deoxygenation (Hebbel et al., 1980b). This
has been demonstrated under static and flowing conditions
using both human and bovine endothelium and cultured
endothelial cells (Hoover et al., 1979; Hebbel et al.,
1981). Hebbel et al. (1980a) also reported that the ability
of sickle cells to adhere to endothelium correlates
positively and significantly with differences in the
severity of vaso-occlusion among sickle cell anemics. Other
studies from these investigators suggest also that the
membrane abnormality responsible for endothelial adherence
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is an abnormal surface distribution of sialic acid (Hebbel
et al., 1980b). Mohandas and Evans (1984) developed a
micromechanical technique which showed that over 85% of
sickle cells adhere to endothelial cells compared to less
than 20% of normal cells. They also showed that over 90% of
dense sickle cells suspended in autologous plasma adhered to
endothelial cells in contrast to less than 20% adherence of
the same population of cells suspended in normal plasma.
Their findings suggest that both cell membrane changes and
plasma factors contribute to adherence of sickle cells to
vascular endothelium, which may have important implications
for the pathophysiology of sickle cell disease.
Sickle cells have increased cell calcium (Eaton et al.,
1973) and consequently, decreased potassium, total cations
and cell water (Segal et al., 1972; Glader, 1974). The
mechanism by which calcium becomes elevated in sickle cells
is still not clear. Bookchin and Lew (1980) suggested that
progressive calcium pump failure due to the repetitive
sickling process results in increased cell calcium.
However, Luthra and Sears (1982) have shown that sickle
cells have normal Ca'*’^ATPase activity and therefore, the
calcium pump should function normally. They proposed that
the elevated calcium level in sickle cells is due to an
increased calcium leak, abnormal calcium binding or
"sequestration” of calcium from pump sites. The latter
hypothesis was confirmed by Rubin et al. (1986) in
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experiments employing fluorescent probes. They showed that
sickle cells, unlike normal cells, contain internal membrane
vesicles formed by endocytosis (upon deoxygenation), within
which calcium is sequestered.
Sickle cells have decreased cell water content. This
occurs as a result of the action of the Gardos effect (i.e.,
influx of Ca^^, efflux of K'*’ and water). Studies by Clark
et al. (1980a) have demonstrated that the state of cell
hydration greatly influences morphology and cell
deformability by changing the mean corpuscular hemoglobin
concentration (MCHC) and intracellular viscosity. They
showed that the deformability of oxygenated ISCs, which are
more dehydrated than non-ISCs, can be restored when cell
water content is increased. The cells also regain their
normal shape.
The above cellular defects arise from the behavior of a
defective hemoglobin. Sickle hemoglobin (HbS), differs from
normal hemoglobin (HbA) in that the amino acid, valine, is
substituted for glutamic acid at the sixth position of each
beta chain of adult hemoglobin. This basic alteration is
responsible for changes in the physical properties of the
molecule. Pauling et al. (1949) demonstrated that HbS
migrates more rapidly than HbA toward the cathode in an
electrophoretic field. Solubility studies have shown that
oxygenated HbS is more unstable (i.e., readily denatured)
upon mechanical shaking than HbA (Asakura et al., 1974).
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In dilute solutions, HbS has normal functional
properties including oxygen affinity, heme-heme interaction,
Bohr effect, and reactivity with 2,3-diphosphoglycerate
(DPG) and CO2 (Bunn, 1972; Rossi-Bernardi et al., 1975).
However, concentrated solutions of HbS and HbA differ
markedly. In contrast to HbA, deoxygenated HbS aggregates
to form polymers through hydrophobic interactions (Murayama,
1966). The polymerization of HbS is the pathophysiological
basis for sickling.
The structure of polymerized deoxy HbS was originally
thought to be a structure similar to a microtubule
consisting of rings of six hemoglobin tetramers (Finch et
al., 1973). X-ray diffraction measurements of a true
crystal of deoxy HbS indicated a molecular structure of
paired strands of hemoglobin tetramers (Wishner et al.,
1975) which may make up a helical fiber. Analysis by
electron microscopy indicates that the polymerized
hemoglobin fiber is a helical structure with possibly 14 or
16 hemoglobin tetramers in each layer (Dykes et al., 1978;
Wellems and Josephs, 1979). This most recent structural
model of the HbS polymer is consistent with evidence derived
from studies on the effects of mutated chains on the
polymerization of HbS (Benesch et al., 1977).
Studies employing ^^C-nuclear magnetic resonance (NMR)
measurements have shown there is a direct correlation
between the variability of the anemia (i.e.. the
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concentration of red cells in blood), the severity of the
vaso-occlusion manifestation and the presence of HbS polymer
even under oxygenated conditions (Brittenham et al., 1985).
HbS aggregates can be detected in cells with no morphologic
abnormality (Bookchin et al., 1976). While observing
rheologic properties of sickle cells at high oxygen
saturations, Chien (1977) noted HbS polymers in undeformed
cells. Hahn et al. (1976) provided further evidence of this
phenomenon using time-lapsed ultrastructural examination of
cells immediately after deoxygenation. These results
support the hypothesis that the intracellular polymerization
of HbS is the primary determinant of the pathology of
sickling hemoglobinopathies (Brittenham et al., 1985).
However, to fully explain the clinical manifestations in
sickle cell anemia, further investigation is needed to
clarify the mechanisms underlying the secondary phenomenon,
namely, adherence to endothelial cells, intracellular
metabolic changes and membrane-associated abnormalities and
how the primary defect is involved.
One approach to understanding the membrane-associated
abnormalities which occur in the sickle erythrocyte is to
search for alterations in molecular composition of the
membrane. Analysis of red cell membrane proteins can be
readily achieved by employing the continuous Tris-Acetate
buffer electrophoresis system of Fairbanks et al. (1971), in
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which proteins are solubilized in sodium dodecyl sulfate
(SDS) and separated according to molecular weight.
One of the most abundant red cell membrane proteins is
spectrin. It consists of two subunits, designated bands 1
and 2 according to the nomenclature of Fairbanks et al.,
(1971). These subunits have molecular weights of 240,000
and 220,000 daltons, respectively (Branton et al., 1981).
Spectrin is also the major peripheral membrane protein and
is the major component of the membrane skeleton. Band 3,
which has a molecular weight of 95,000 daltons, is the major
transmembrane protein and is responsible for anion transport
(Steck, 1978; Rothstein et al., 1979). Actin, which is
designated band 5 (mol. wt. 42,000 daltons), is the second
most prominent membrane skeleton protein.
Separation of proteins can be further improved by
employing the Laemmli Tris-Glycine discontinuous buffer gel
electrophoretic system, which is particularly suitable for
resolving polypeptides between the molecular weight range of
40,000 to 80,000 daltons (Laemmli, 1970). Band 4.1, which
is yet another component of the red cell membrane skeleton,
can be separated into two components, bands 4.1a and 4.1b
(mol. wt. 80,000 and 78,000 daltons, respectively) using
this particular system.
Riggs and Ingram (1977) reported that there were
differences in the protein composition of normal and sickle
membranes. They observed a decrease in band 3, increases in
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bands 4.5, 6, and 7 and the appearance of band 8 (hemoglobin
dimer). However, Durocher and Conrad (1974) and Balias and
Burka (1980) observed no differences in protein composition
of normal and sickle membranes. Discrepancies among these
studies may be attributed to differences in membrane
preparation and/or the resolution of membrane proteins by
the particular gel system used by each investigator.
Therefore, further studies in this area are warranted.
Recent investigations have shown that erythrocyte
membrane proteins may be modified by phosphorylation and
methylation. Phosphorylation of serine and threonine
residues have been demonstrated in both isolated membranes
and intact cells (Avruch and Fairbanks, 1974; Shapiro and
Marchesi, 1977). Spectrin band 2 is a phosphoprotein and
its state of phosphorylation has been associated with
changes in erythrocyte ghost morphology and deformability
(Sheets and Singer, 1977). However, studies by Anderson and
Tyler (1980) demonstrated that the state of phosphorylation
did not affect erythrocyte shape or spectrin binding to
erythrocyte membranes. To understand the functional role of
spectrin phosphorylation, more general knowledge on the
chemical relationship between phosphorylation and function
is necessary.
Phosphorylation of membrane proteins of intact sickle
cells was found to differ from normal cells. The amount of
radiolabel incorporated into spectrin band 2 was less while
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incorporation into band 4.5 was more than in normal cells
(Dzandu and Johnson, 1980). The role of phosphorylation of
proteins in the pathogenesis of the sickle cell membrane
defect remains uncertain (Palek, 1980).
Protein methylation in erythrocytes has been shown in
in vitro and iji vivo studies to occur at aspartyl residues
in integral membrane proteins such as glycophorin A and band
4.5 (Kim et al., 1980). Carboxyl methyltransferase (S-
adenosyl-L-methionine protein carboxyl 0-methyltransferase
II), a protein present in the cytosol, catalyzes the
methylation of proteins using S-adenosyl-methionine as the
methyl group donor (0-Connor and Clarke, 1983). Although
the role of methylation of membrane proteins remains
unclear, the neutralization of anionic charges in proteins
by methyl ester formation could have an affect on membrane
structure and function (Kim et al., 1980).
Methylation of erythrocyte membrane components in
sickle cell anemia has been studied and found to differ
considerably from that of normal erythrocytes (Ro et al.,
1981). When sickle cells were incubated under physiological
conditions (pH 7.4, 37°C) in the presence of S-adenosyl-L-
[methyl-^H] methionine, a 50% decrease in the protein-
carboxyl methylation was observed compared to normal cells.
Sickle cell ghosts showed the same 50% decrease in
methylation as was seen in the intact cells. Since it was
also shown that the protein methylase II and methyl acceptor
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membrane protein levels in the sickle erythrocyte are the
same as the normal, these results suggest that the observed
reduced methylation may be due to an altered membrane
conformation (Ro et al., 1981).
Knowledge of membrane protein-protein interactions has
been greatly advanced through the use of crosslinking
reagents in conjunction with SDS-polyacrylamide gel
electrophoresis. Most crosslinking reagents are small
organic molecules containing one to two chemical groups
which are reactive towards the functional groups on the side
chains of proteins. However, the crosslinking reagent O-
phenanthroline/copper sulfate is a molecule which catalyzes
the oxidation of sulfhydryl groups of two adjacent proteins
to form a linkage. Crosslinking reagents are useful in
defining the proximity of neighboring proteins and studying
quaternary structure. These reagents produce covalent
linkages between proteins which result in crosslinked
complexes in a higher position in the gel than the
individual proteins, when proteins are fractionated
electrophoretically on the basis of size.
Steck (1972) undertook the first systematic
investigation of chemical crosslinking of human erythrocyte
ghosts using a variety of crosslinking reagents, including
formaldehyde, glutaraldehyde, 0-phenanthroline/copper
sulfate and dinitrobenzene. His studies revealed that band
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3 exists in the membrane as a dimer and that bands 1 and 2
are closely associated ^ situ.
Cleavable crosslinking reagents such as dithiobis-
succinimidyl propionate (DTSP) and dithiobispropionimidate
(DTBP) have been very useful in nearest-neighbor analysis.
These crosslinking reagents allow a crosslinked product to
be dissociated into its individual components upon cleavage
with a reducing agent (e.g., dithiothreitol or 2-
mercaptoethanol). Subsequently, the crosslinked proteins
may be identified by one and two dimensional polyacrylamide
gel electrophoresis (Wang and Richards, 1974). Although
investigations on the protein organization of the normal red
cell membrane are ongoing, very few studies have been
directed towards the organization of proteins in the sickle
cell membrane.
Protein-protein interactions have been studied
extensively in the normal erythrocyte. Spectrin, protein
4.1, and actin are three major membrane proteins which
participate in the formation of the erythrocyte skeleton.
Spectrin is a long, filamentous protein composed of two non¬
identical polypeptide chains called alpha-spectrin and beta-
spectrin (also known as bands 1 and 2) which associate to
form a heterodimer (Knowles et al., 1983). One end of the
spectrin dimer is capable of head-to-head self-association
to form tetramers and higher oligomers (Morrow and Marchesi,
1981). The binding site for ankyrin (band 2.1), a 210,000
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dalton protein which links spectrin to the membrane via band
3, is also located at this end of the spectrin dimer
(Bennett and Stenbuck, 1980). At the opposite end of the
spectrin molecule is the binding site for F-actin (Brenner
and Korn, 1979; Cohen and Foley, 1980; Cohen et al., 1980).
The association between spectrin and actin alone is very
weak. However, this interaction is greatly enhanced by
protein 4.1 which forms a stable ternary complex
(Ungewickell et al., 1979; Fowler and Taylor, 1980; Cohen
and Foley, 1984). Protein 4.1, which is composed of two
sequence-related phosphoproteins designated 4.1a and 4.1b
(Goodman et al., 1982), also serves as a link between the
membrane skeleton and the lipid bilayer through its
interaction with the transmembrane glycoproteins,
glycophorin A and band 3 (Anderson and Lovrien, 1984;
Pasternack et al., 1985).
Protein-protein interactions have been studied in
erythrocytes from individuals with various types of
hemolytic anemias. These cells exhibit membrane alterations
which appear to contribute to their cellular abnormalities.
Information gained from the study of these cells may provide
insight into the membrane abnormalities of sickle
erythrocytes.
Hereditary spherocytosis (HS) is a disease resulting in
osmotically fragile and spherocytic (round) red blood cells.
The membrane skeleton appears to be intimately involved in
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this abnormality. Wolfe et al. (1982) concluded that
approximately 40% of spectrin is defective in some HS
individuals and cannot bind band 4.1. Agre et al. (1982)
reported that ghosts of two HS siblings were at least 50%
deficient in spectrin, with band 1 reduced more than band 2.
Goodman et al. (1982) identified the molecular defect in the
N-terminus of spectrin, which serves as the band 4.1 binding
site. He classified this defect as type I HS. The
inability of type I HS spectrin to bind 4.1 leads to a
weakened spectrin-band 4.1-actin ternary complex. These
findings are important to the current understanding of the
molecular basis of hereditary spherocytosis and also
demonstrate the central importance of the spectrin-band 4.1-
actin ternary complex to the structural integrity of the
normal red blood cell.
Hereditary elliptocytosis (HE) is also a disease
characterized by abnormal (ellipsoid) shaped red blood
cells. Studies suggest that membrane skeletal defects are
involved. Tomaselli et al. (1981) reported that HE spectrin
is abnormally heat-sensitive and denatures at a lower
temperature than normal spectrin. Defective spectrin dimer-
dimer associations were observed in some HE patients (Liu et
al., 1982). Some individuals have spectrin that yields
different trypsin-digest fragments when compared to normal
individuals (Coetzer and Zail, 1980; Lecomte et al., 1984;
Lawler et al., 1984; Lawler et al., 1985; Lecomte et al..
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1985; Marches! et al., 1986). Other investigations have
indicated deficient 4.1 in HE membranes (Alloisio et al.,
1981; Cohen and Branton, 1981; Tchernia et al., 1981;
Alloisio et al., 1982; Alloisio et al., 1983; Garbarz et
al., 1984; Alloisio et al., 1985).
Hereditary pyropoikilocytosis (HPP), a rare congenital
hemolytic anemia, is characterized by a small population of
poikilocytes (irregular, malformed cells) and microspher-
ocytes (small, round cells) in the peripheral blood. The
red blood cells of individuals with HPP exhibit
fragmentation and transform to poikilocytes and microsphero-
cytes after iji vitro incubation at 45°C (Ham et al., 1948).
Studies revealed that HPP cells have increased leakage of
calcium from plasma into the cells (Walter et al., 1977) and
decreased extrusion of calcium from the cells (Wiley and
Gill, 1976). Membrane skeletons from HPP cells are very
unstable and are more susceptible to thermal damage iji vitro
than normal ones (Chang et al., 1979). HPP spectrin also
exhibits decreased extractibility from membranes (Wiley and
Gill, 1976). Palek et al. (1981) reported alterations in
the assembly of spectrin in HPP red cell membranes. HPP
cells exhibit a decreased spectrin to band 3 ratio (Coetzer
and Palek, 1984). Other studies have demonstrated an
alteration in the N-terminal 80,000 dalton domain of the
spectrin alpha subunit (band 1) manifested in an increased
susceptibility to mild tryptic digestion (Lawler et al..
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1982; Knowles et al., 1983; Lawler et al.f 1983; Marches! et
al., 1986). These latter studies have shown that this
molecular alteration is responsible for decreased ability of
spectrin dimers to self-associate to form tetramers and
higher oligomers resulting in decreased stability of the
membrane skeleton.
Relatively few inherited hemolytic anemias occur in
animals. A spectrin deficiency in the common house mouse
(Mus musculus) causes a recessively inherited hemolytic
anemia in the animal (Greenquist et al., 1978). The extent
of varying degrees of spectrin deficiency in four mutants
were found to be correlated closely with the severity of the
anemia (Bernstein, 1980). Incorporation of spectrin into
these membranes by exchange hemolysis reduced the abnormal
cell fragmentation and fusion, thus modulating the marked
aberrant osmotic behavior of these erythrocytes (Shohet,
1979). Smith et al. (1983) have studied a dog with
persistent hereditary elliptocytosis and found the membranes
to be deficient in band 4.1.
The defects in the diseases described above have all
been attributed to abnormalities in components of the
membrane skeleton. Further knowledge on the mechanisms
involved in producing the abnormal properties in the sickle
cell could possibly lead to an effective therapeutic




A. Source of Blood
Sickle blood was obtained from the Sickle Cell
Foundation of Georgia (Atlanta/ Georgia), Herman Harris,
Administrative Officer of the Comprehensive Sickle Cell
Center of the Medical College of Georgia (Augusta, Georgia),
and Dr. James Eckman, Director of the Sickle Cell Clinic at
Grady Hospital (Atlanta, Georgia). The blood obtained had
been identified as homozygous for the sickle (S/S) gene and
was from individuals who had not been transfused within a
three month period prior to phlebotomy. Normal (A/A) blood
was obtained from paid volunteers.
B. Fractionation of Red Blood Cells
Blood was transferred to clinical centrifuge tubes and
centrifuged for ten minutes (min) in a Dynac Clinical
Centrifuge at 100 rpm at 4°C. The plasma and buffy coat
consisting of leukocytes were removed and discarded. The
remaining packed cells were suspended in wash buffer, 5 mM
NaP04, 0.15 M NaCl, pH 8.0 [5PN(8)1, centrifuged as
described above and the supernate discarded. This was
repeated twice.
The procedure of Abraham et al. (1975) was used for
fractionating red blood cells. Dextran 40 (mol. wt. 40,000)
solutions of various concentrations were prepared by
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dissolving the appropriate quantities in a suspension medium
consisting of 0.585 M KH2PO4, 3.141 M NaH2P04*H20, 8.6 M
Glucose, 6.277 M NaCl 0.096 M MgS04, pH 7.4 (Appendix A).
A discontinuous gradient ranging from 24-34% Dextran 40
with a total volume of 30 ml (5 ml/layer) was prepared and a
blood volume of 1.5 to 2.0 ml was gently layered on each
gradient. The blood was centrifuged in a Beckman 25.1 or
28.1 swinging bucket rotor at 90,200 x g for 90 min at 4°C
in a Beckman L5-50 Ultracentrifuge.
After centrifugation, the cells were separated into
five distinct bands and a pellet. The first two bands were
combined to yield the top fraction, the next two bands were
combined to yield the middle fraction, and the last band and
pellet were combined to yield the bottom fraction.
Fractions were suspended in 5PN(8) and centrifuged in a
Beckman JA-20 Preparative Centrifuge or equivalent at low
speed (1210 x g) at 4°C for 10 min to remove the dextran.
The supernatant fraction was discarded and the wash
procedure was repeated twice.
C. Scoring of Reticulocytes
One volume of blood was added to two volumes of
reticulocyte stain (1.0 g New methylene blue in 100 ml
citrate-saline) and allowed to stand at room temperature for
20 min. Subsequently, a blood smear was prepared on a slide
which was allowed to dry at room temperature. Smears of
each fraction were viewed with a Swift International Phase
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Contrast Microscope. Reticulocytes were characterized as
lightly-stained cells retaining darkly-stained reticulum in
the center of each cell. A total of 1000 cells were counted
to determine the percentage of reticulocytes in each
fraction.
D. Scoring of Irreversible Sickled Cells
Packed cells were resuspended in 5PN(8) and incubated
under 95% oxygen and 5% carbon dioxide for 5 min with mild
agitation. An aliquot of suspended blood was removed and
fixed in 1% Glutaraldehyde in Hepes-Ringer buffer (154 itiM
NaCl, 5.7 mM Na2HP04, 4.86 mM KCl, 0.54 mM CaCl2f 1.22 mM
MgS04/ 25 mM Hepes and 5.5 mM Glucose). Unfractionated and
fractionated cells were viewed with a Swift International
Phase Contrast Microscope. ISCs were defined as elongated,
crescent-shaped cells whose length to width ratio was
greater than 2:1 or cells with sharp angular contours
(Jensen et al., 1960). A total of 500 cells were counted to
determine the percentage of ISCs in each sample.
E. Pyruvate Kinase Enzyme Assay
The procedure of Seaman et al. (1980) for measuring
pyruvate kinase activity was employed to determine whether
the dextran gradient was fractionating cells by age.
Pyruvate kinase activity is high in young cells
(reticulocytes) and declines with the age of the cell.
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All assays were performed at 25°C at 340 nm in a
Beckman DU-7 Spectrophotometer. Immediately before each
assay/ the cells of each fraction were hemolyzed in5mMN-
Tris-(hydroxymethyl)-methyl-2-aminoethane sulfonic acid
(TES)/ pH 7.4, containing 1 mM 2-mercaptoethanol and 1 rtiM
disodium EDTA. The hemoglobin concentration of each
hemolysate was measured by conversion to cynamethemoglobin
using a hemoglobin determination kit (Sigma Chemical Co.).
A hemoglobin concentration of 0.06 gm/ml was used for each
fraction to standardize the amount of sample in each assay.
The following components were added together in a 1 ml
reaction mix at the following final concentrations: 2.7 mM
phosphoenol pyruvate (PEP), 2.5 mM ADP, 0.1 mM NAOH, 4 mM
MgCl2, 85 mM KCl and 4 units lactate dehydrogenase. The
rate of substrate utilization was computed from the change
in absorbance using the molar extinction coefficient for NAD
(6.22 x 10^ mM). Results were expressed in micromoles of
substrate converted per minute per gram of hemoglobin.
F. Solubilization of Whole Cells
Fifty microliters (ul) of packed cells washed in 5PN(8)
in the presence and absence of proteolytic inhibitors, 2 mM
diisopropylfluorophosphate (DFP) or 3 mM phenylmethyl-
sulfonyl-fluoride (PMSF), were immediately lysed and
solubilized in a solution containing 150 ul distilled water,
200 ul Laemmli sample buffer, 80 ul 20% SDS and 12 ul of
100% 2-mercaptoethanol (Appendix D). The mixture was heated
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for 2 min at 100°C and allowed to cool before
electrophoresis or storage at -20°C.
G. Preparation of Membranes^ Cytoplasm and Membrane
Skeletons
The method of Fairbanks et al. (1971) was employed for
preparing membranes. Intact cells were washed 3 times with
an isotonic buffer, 5PN(8), in the presence or absence of 2
mM DFP or 3 mM PMSF, in a clinical centrifuge, and then
lysed in the hypotonic buffer 5 mM NaP04, pH 8.0 [5P(8)] in
the presence or absence of 2 mM DFP or 3 mM PMSF. The lysed
cells were centrifuged at 30,965 x g in a Beckman JA-20
preparative centrifuge or equivalent for 10 min at 4°C. The
supernatant fraction (cytoplasm) was removed by aspiration
and a sample from the top was solubilized as described for
whole cells. The remainder of the supernatant fraction was
discarded. The brownish pellet (leukocyte button) which
remained stuck to the bottom of the centrifuge tube was
aspirated and discarded. The reddish pellet (membranes) was
resuspended in the appropriate 5P(8) buffer with or without
DFP or PMSF and centrifuged as before. The membranes were
washed 4 to 5 times in the same buffer to remove as much of
the hemoglobin as possible.
Cytoskeletal complexes from membranes were prepared
according to the procedure of Sheetz (1979) with
modifications. Membranes were suspended 1:1 (v/v) in
extraction buffer (0.6 M KCl, 48 mM Hepes, 1.0 mM MgCl2#
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0.05 mM CaCl2/ pH 7.4) in the presence or absence of 2 mM
DFP, containing 4% Triton X-100. The suspended membranes
were extracted for 30 min in an ice bath {4°C) on a rotary
shaker. Subsequently, the sample was centrifuged for 30 min
in a Beckman JA-20 Preparative Centrifuge or equivalent at
43,666 X g at 4°C. The supernatant fraction, containing
proteins soluble in Triton X-100 detergent, was aspirated
and discarded. The pellet was suspended in 5P(8) buffer and
centrifuged for 10 min. This procedure was repeated once to
ensure removal of excess salts. The pellet was resuspended
in 1.0 to 3.0 ml of the appropriate 5P(8) buffer depending
on the size of the pellet.
The membranes and membrane skeletons were assayed for
protein content by the Lowry (1951) or Bradford (Bio-Rad)
(1976) method. Samples were then solubilized by adding one-
half the volume of Laemmli sample buffer and gently vor-
texed. They were immediately subjected to electrophoresis
or stored at -20°C.
H. Crosslinkinq of Membranes
1. 0-phenanthroline/Copper Sulfate (0-phe)
Various concentrations of 0-phe, ranging from 1 mM to
10 mM, were prepared in 5P(8). Twenty volumes of membranes
(at a protein concentration of 2 mg/ml) were added to one
volume of 0-phe. Incubations were carried out at various
time intervals from 0 to 60 min at room temperature. The
crosslinking reaction was stopped by adding 4X Fairbanks
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solubilizing buffer (Appendix III) at one-fourth the volume
of membranes (Appendix II). Dithiothreitol (DTT) was added
to control membranes at 0.0248 gm/ml of solubilized sample.
2. Glutaraldehyde
Membranes were treated with various concentrations of
glutaraldehyde (1 mM to 5 mM) prepared in 5P(8) at room
temperature. Glutaraldehyde was added to membranes (2 mg
protein/ml) in a 1:2 (v/v) ratio and the reaction mixture
was allowed to incubate from 0 to 20 min. The crosslinking
reaction was stopped by the addition of 4X Fairbanks
solubilizing buffer containing 0.0248 gm/ral DTT to the
solubilized sample at one-fourth the volume of membranes
(Appendix B).
3. Dithiobis(succinimidyl propionate) (DTSP)
Various concentrations of DTSP (2 mM to 10 mM) in
dimethylformamide were prepared immediately before use.
DTSP was added to membranes (2 mg protein/ml) in a 1:5 (v/v)
ratio and was incubated at room temperature from 0 to 15 min
Crosslinking was quenched by adding 30 mM NEM, 3% SDS, 1
mg/ml Pyronin y in 50 mM Sodium phosphate at one-fifth the
volume of membranes (Appendix B).
4. Dimethyl 3y3'-dithiobispropionimidate (DTBP)
DTBP was dissolved in 5PN(8) at 5, 10, and 15 mg/ml
immediately before use. One volume of DTBP was added to 2
volumes of membranes (2 mg protein/ml) and allowed to
incubate at room temperature for 0 to 2 h. Crosslinking was
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terminated with 1 ul of 1 M ammonium acetate (NH3AC) for
every 20 ul of membranes. After addition of NH3AC, the
reaction was incubated at room temperature for 10 min and
subsequently, solubilized in 20 mg/ml N-ethylmaleimide
(NEM), 20% SDS, 1 mg/ml Pyronin y at one-half the volume of
membranes (Appendix B).
5. Dimethyladipimidate (DMA)
Various concentration of DMA (1 to 20 mM) were prepared
in 0.5M Triethanolamine, pH 8.0. The crosslinking reagent
was added to the membranes at one-fourth volume and
incubated at room temperature for 0 to 60 min. The reaction
was stopped by the addition of solubilizing buffer
containing 60 mM Tris-HCl, pH 6.8, 2.5% SDS, 1 mg/ml Pyronin
y, and 0.16M DTT at one-fourth the volume of membranes
(Appendix B).
I. Polyacrylamide Gel Electrophoresis
1. One-dimensional SDS-polyacrylamide Gel
Electrophoresis
One-dimensional SDS-polyacrylamide gel electrophoresis
(1-D SDS-PAGE) was performed as described by Fairbanks et
al. (1971) for cylindrical (tube) gels. A 4% acrylamide gel
solution was prepared from a 30% acrylamide/0.8%
bisacrylamide stock and lOX Tris-Acetate buffer. Catalysts,
tetramethylethylenediamine (TEMED) and ammonium persulfate
(AP), were added to initiate the polymerization process
(Appendix C). The solution was poured in glass cylindrical
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tubes (5 nun i.d. x 10.5 cm) and immediately overlayered with
butanol to prevent the gel from being exposed to air and to
insure a flat top surface on the gel. The gels were allowed
to polymerize for at least 1 h before removing the butanol,
rinsed several times with distilled water and mounted in a
Hoeffer Cylindrical Gel Apparatus. The upper and lower
reservoirs were filled with Fairbanks electrophoresis buffer
(Appendix C). The top chamber was agitated gently to remove
air bubbles from the bottom of the tubes (to insure an even
flow of current). The samples were applied with a standard
microliter pipettor or a Hamilton syringe. The current from
the power supply was adjusted to 8 milliamperes (ma) per
gel. After electrophoresis (approximately 1 to 2 h), the
gels were extruded from each tube by rimming each with
distilled water from a 22 gauge needle attached to a 10 ml
syringe. The location of the tracking dye on each gel was
marked with India ink. The gels were stained in a solution
of 0.05% Coomassie blue R (CB-R), 25% isopropyl alcohol (lA)
and 15% acetic acid (HAc) for a minimum of 12 h. They were
then destained in 10% lA and 10% HAc until the background
was clear. After destaining, the gels were viewed using a
fluorescent lamp box.
The Laemmli (1970) 1-D SDS-PAGE system was employed for
preparing slab gels. In order to maximize resolution, a
separating gel consisting of a linear gradient from 5% to
15% acrylamide was used for analyzing samples (Appendix D).
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Gels were prepared in the Bio-Rad Protean I Vertical Slab
Gel Apparatus with glass plates (16 cm x 18 cm). The plates
were assembled with 1.5 cm spacers and mounted onto the
casting stand. A 5% and 15% gel solution was prepared, each
of which had a total volume of 15 ml, followed by the
addition of 4 ul of 100% TEMED and 70 ul 10% AP to each
(Appendix D). A gradient maker mounted on a stirring base
was employed to pour the separating gel. The 15% gel
solution was poured into the exit chamber of the gradient
maker and the valve connecting the two chambers was opened
briefly to allow back flow of a small amount of the solution
to prevent entrapment of air bubbles in the canal between
the chambers. The solution was pipetted back into the exit
chamber before the 5% gel solution was added to the other
chamber. Stirring bars were added to each chamber and the
stirring base was turned on to insure adequate mixing of the
solutions for the linear gradient. The valves for each
chamber were turned on to allow the solution to flow in
between the glass plates. After the solutions filled
approximately three-fourths the volume between the glass
plates, the solution was overlayered with butanol and
allowed to polymerize for at least 1-2 h. The butanol was
removed and the gel was rinsed several times with distilled
water. All water was removed by aspiration with a syringe
and blotting the interface of the gel with a soft tissue.
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A 4.5% stacking gel solution was poured between the
glass plates and a 10-well comb was inserted into the
solution to form the lanes for the sample application
(Appendix D). After 30 min, the comb was carefully removed
and the lanes were cleaned out with distilled water and a
syringe.
The casted gel was placed in the electrophoresis
apparatus and Laemmli electrophoresis buffer was added to
the top and lower buffer chamber. The current was adjusted
to 20 ma per gel. After electrophoresis (approximately 5-7
h), the gel was removed from the glass plates and placed in
a staining solution containing 1% Coomassie blue G (CB-G) in
50% methanol (MeOH) and 10% HAc and stained for 30 min to 1
h or the gel was placed in the appropriate fixative for
other staining procedures.
2. Isoelectric Focusing (lEF)
Isoelectric focusing (lEF) was performed as described
by O'Farrell (1975) with some modifications. Five percent
acrylamide gels containing 2% ampholytes were prepared in
cylindrical glass tubes (5 mm i.d. x 10.5 cm) and
overlayered with butanol (Appendix E). After 2 to 3 h, the
butanol was replaced with 20 ul of sample overlayer solution
and the gel was allowed to sit for another 1 to 2 h.
Subsequently, the gels were mounted in a tube gel apparatus.
The upper (cathode) buffer chamber was filled with 0.025 H
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NaOH and the lower (anode) buffer chamber was filled with
0.06 M H2SO4.
The protein samples were solubilized in treatment
buffer containing 2% NP-40 and 5% 2-mercaptoethanol in a 2:1
ratio (v/v) (Appendix E). The samples were boiled for 5 min
followed by cooling. Crystalline urea was added to
saturation (9 M urea), then the samples were centrifuged for
2 min in a Brinkmann Micro Centrifuge. The supernatant
fraction was placed on the gels and subjected to
electrophoresis for 12 h at 400 volts and for 1 h at 800
volts.
Proteins were identified by the staining procedure of
Tuszynski et al. (1978). Gels were fixed in 12.5%
trichloroacetic acid (TCA) for 2 h to precipitate SDS. This
solution was followed by a second fixative containing 25%
IA/15% HAc to remove the SDS, which changes the gels from an
opaque white color to clear. Subsequently, the gels were
placed in the CB-R staining solution mentioned above. The
gels were destained in two changes of 25% IA/15% HAc for 30
min each, followed by 10% IA/10% HAc overnight.
J. Two Dimensional SDS-Polyacrylamide Gel Electrophoresis
1. Two-dimensional Diagonal SDS-polyacrylamide Gel
Electrophoresis (2-D SDS-PAGE)
The procedure of Wang and Richards (1974) was employed
for 2-D SDS-PAGE with some modifications. Slab gels were
prepared for the second dimension (2-D) as described above
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using a 4%-17% linear gradient (Appendix F). The gel
solution was poured up to approximately 2 cm from the top of
the glass plates. A 4.5% stacking gel was poured to the top
and overlayered with butanol. After polymerization, the
butanol was replaced with a solution containing 0.16M DTT in
0.5 mg/ml pyronin y. This was allowed to percolate into the
gel for a minimum of 30 min. The solution was removed prior
to applying the first dimension (1-D) gel.
Samples were subjected to electrophoresis on 4%
Fairbanks gels (l-D) as described above. After
electrophoresis, the tube gels were removed and each was
placed on top of a slab gel. The 1-D gel was sealed in
place by a heated solution of 1% agarose in Laemmli
electrophoresis buffer. The agarose was allowed to cool
prior to electrophoresis. After electrophoresis, gels were
stained with coomassie blue or silver stain.
2. Two-dimensional SDS-polyacrylamide Gel
Electrophoresis (lEF/SDS-PAGE)
The procedure of O'Farrell (1975) was employed for
lEF/SDS-PAGE. Slab gels were prepared as described in the
above section. Isoelectric focused (lEF) gels were
equilibrated in 0.0625 M Tris-HCl, pH 6.8, 2% SDS, 10%
glycerol and 5% 2-mercaptoethanol for 10 min. The lEF gels
were sealed on to the slab gel with 1% agarose in Laemmli
electrophoresis buffer and subjected to electrophoresis.
Gels were stained with coomassie blue or silver stain.
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K. Silver Staining Procedures
The procedures employed for silver staining were Bio-
Rad Silver Stain Kit (Merril et al., 1980), purchased from
Bio-Rad Laboratories, Richmond, California (Appendix F) and
Tsang et al. (1984) (Appendix G).
L. Gelcode Staining Procedure
Commercial Gelcode (modified silver stain) kits were
employed to stain 1-D gels (Appendix H). The kits were
purchased from Health Products, Inc., South Haven, Michigan.
M. Kodavue Staining Procedure
Kodavue (nickel stain) kits purchased from Eastman
Kodak Company, Rochester, New York were employed for
staining 1-D slab gels (Appendix I).
N. Densitometry
Densitometric scans of gels were performed at a wave
length of 550 nm with a slit width of 2 nm using a Beckman
DU-8 Spectrophotometer. Adjustable gel slit masks of 0.1 mm
and 1.0 mm were combined together to improve resolution
between protein bands.
O. Photography
Gels were photographed with a Polaroid 622 Land Camera
using black and white Polaroid Type 622 film. In some
cases, a 35 mm Nikon camera with 135 Kodachrome film was
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used. A Kodak Wratten yellow filter #12 was used to enhance




A. COMPARISON OF THE PROTEIN COMPOSITION OF NORMAL AND
SICKLE MEMBRANES
In this study, one-dimensional SDS-polyacrylamide gel
electrophoresis (1-D SDS-PAGE), isoelectric focusing (lEF)
and two-dimensional SDS-polyacrylamide gel electrophoresis
(2-D SDS-PAGE) in conjunction with a variety of stains were
employed to determine whether there were differences in
protein composition between normal (A/A) and sickle (S/S)
membranes.
When membranes from normal and sickle cells were
subjected to electrophoresis on 5% - 15% acrylamide Laemmli
gradient gels (1-D SDS-PAGE) followed by staining with
coomassie blue, the most striking difference observed was an
increase in staining intensity in protein band 4.1b in
sickle membrane preparations (Fig. 1). Densitometric scans
of gels in which normal and sickle membrane proteins were
fractionated by electrophoresis showed that there was a two¬
fold increase in the amount of band 4.1b in sickle membranes
(Fig. 2 and 3). Other differences were also observed in
sickle membranes such as additional proteins in the band 4.5
region previously reported by Riggs and Ingram (1977), and
increased hemoglobin previously reported by Fischer et al.
(1975) (Fig. 1).
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Figure 1. Comparison of normal (A/A) and sickle (S/S)
membrane protein profiles on a SDS-
polyacrylamide Laemmli gel stained with
coomassie blue. The alteration in protein
band 4.1b is indicated by the arrow.
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COOMASSIE
Figure 2. Densitometric scans of membrane protein
profiles of normal (A/A) membranes (top
panel) and sickle (S/S) membranes (bottom
panel). The alteration in protein band 4.1b.






Figure 3. Densitometric scans of the band 3/4.1 region
of normal (A/A) (top panel) and sickle (S/S)
membranes (bottom panel). The alteration in






In recent years, additional stains besides coomassie
blue have been used to stain proteins in polyacrylamide
gels. Some of these stains, inlcuding silver, gelcode
(modified silver stain) and kodavue (nickel) are 100 times
more sensitive than coomassie blue. These stains were also
employed in this study in order to search for additional
alterations in sickle cell membrane protein composition.
The Bio-Rad Silver Stain procedure (Merril et al.,
1980) proved to be more sensitive in detecting minor
proteins in both normal and sickle membrane samples relative
to coomassie blue (Fig. 4). Yet, spectrin (bands 1 and 2),
band 4.9, band 5, band 7 and a few minor proteins in the
band 8 region were negatively stained and visualization of
band 4.1a and b was obscured due to overstaining of
glycoproteins in this region. Therefore, in an attempt to
improve visualization of these membrane proteins, gels
stained with coomassie blue were followed by staining with
silver (Bio-Rad), a double-staining method developed by
Dzandu et al. (1984). An interesting difference was
detected with this procedure which was not detected by
coomassie blue or silver stain alone. A high molecular
weight (hmw) band above the spectrin region was observed in
sickle samples (Fig. 5). Since this band is of higher
molecular weight than the largest polypeptide in the normal
cell membrane (band 1), it is presumably an aggregate of
polypeptides. Yet, when sickle samples were heated and
Figure 4. Comparison of normal (A/A) and sickle (S/S)
membrane protein profiles on a SDS-




Figure 5. Comparison of normal (A/A) and sickle (S/S)
membrane protein profiles on a SDS-
polyacrylamide Laemmli gel stained with
coomassie blue and silver. The arrow
indicates the high molecular weight (hmw)
complex in the S/S sample.
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treated with either 1.6 M DTT, 20% 2-mercaptoethanol or 8 M
urea, prior to electrophoresis, the amount of band was not
reduced (Fig. 6). These results indicate that the
association of polypeptides in the complex is not due to
weak interactions and/or disulfide bonds.
The silver stain procedure of Tsang et al. (1984) was
also employed to study sickle and normal membranes. This
staining procedure proved to be more sensitive in staining
proteins in the low molecular weight region relative to the
Bio-Rad silver staining procedure. Proteins not only were
colored differently after staining with the procedure of
Tsang et al., but were stained with greater intensity (Fig.
7). Bands 4.1a and b were obscured by overstaining of
glycoproteins as was observed employing the Bio-Rad silver
stain. Also, the hmw complex was not detected. No
additional differences between sickle and normal membranes
were detected employing this stain.
Gelcode is a modified silver stain kit purchased from
Health Products. It stains most of the membrane proteins
yellow in contrast to the various colors observed in the
other silver staining procedures (Fig. 8). In addition to
the band 4.1b alteration, several additional alterations in
minor proteins were detected with this stain. The increase
in band 4.1b was detected as well as an intensely-stained
protein in the band 4.5 region. There was a decrease in a
protein between band 5 and 6 (see arrow). It must be noted
Figure 6. The effect of protein-pertubants on the high
molecular weight complex in sickle membranes.
Sickle membranes were treated with 1.6 M DTT,
20% beta-mercaptoethanol and 8 M urea, after
heating, prior to electrophoresis on a SDS-
polyacrylamide Laemmli gel. The gel was
stained with coomassie blue and silver.
Lanes (1) untreated normal membranes, (2)
untreated sickle membranes, (3) sickle
membranes treated with 1.6 M DTT, (4) 20%
beta-mercaptoethanol and (5) 8 M urea. The
high molecular weight complex is designated
hmw
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Figure 7. Comparison of normal (A/A) and sickle (S/S)
membrane protein profiles on a SDS-
polyacrylamide Laemmli gel stained with
silver (Tsang et al., 1984).
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TSANG
Figure 8. Comparison of normal (A/A) and sickle (S/S)
membrane protein profiles on a SDS-





that these alterations were observed in only two sickle
samples and therefore more samples should be analyzed to
determine whether they are reproducible.
Analyses employing kodavue showed no differences
between normal and sickle membranes. Generally, kodavue
exhibited lower sensitivity in staining than the other
protein stains including coomassie blue (Fig. 9).
Isoelectric focusing in conjunction with SDS-
polyacrylamide gel electrophoresis (lEF/SDS-PAGE) was also
employed to determine whether additional differences could
be detected between normal and sickle membranes. Two-
dimensional gel electrophoresis (lEF/SDS-PAGE) greatly
improves the resolution of proteins in complex systems by
separating the proteins according to their isoelectric
points (pi) in the first dimension followed by separating
them according to their size (molecular weights) in the
second dimension.
Prior to electrophoresis in the second dimension, lEF
gels were stained with coomassie blue and the protein
pattern of sickle and normal membranes was compared to
determine whether differences were evident. A unique band
near the cathode end was observed in lEF gels of sickle
membranes (Fig. 10). it was conceivable that this protein
was sickle hemoglobin since Pauling et al. (1956) showed
that this abnormal molecule migrates slower to the anode
relative to normal hemoglobin. To determine whether this
Figure 9. Comparison of normal (A/A) and sickle (S/S)
membrane protein profiles on a SDS-




Figure 10. Comparison of Normal (A/A) and Sickle (S/S)
membrane and cytoplasmic protein profiles on
isoelectric focused gels stained with
coomassie blue. Lane (1) normal membranes,
(2) sickle membranes, (3) normal extensively
washed membranes, (4) sickle extensively
washed membranes, (5) normal cytoplasm and
(6) sickle cytoplasm. Isoelectric focused
gels extend from the cathode (top) to the
anode (bottom) with a pH gradient of 7.6 to
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protein was indeed sickle hemoglobin, samples of extensively
washed membranes from normal and sickle cells and the
cytoplasms from normal and sickle cells (which contain
primarily hemoglobin) were subjected to lEF. An intensely
stained band migrating near the cathode was observed in the
cytoplasm from sickle cells (Pig. 11). This protein appears
to be the same protein observed in sickle membranes and
seems to be less prominent upon extensive washing of the
membrane sample (Fig. 10). These results suggest that this
protein is sickle hemoglobin.
When normal and sickle membranes were subjected to two-
dimensional gel electrophoresis (lEP/SDS-PAGE), a number of
spots were dectected in the band 4.5 region in sickle
samples after staining with coomassie blue (Fig. 11). It is
conceivable that these spots represent adsorbed cytoplasmic
proteins, however it is unclear why these bands were not
visible in the first dimension. Another explanation for the
additional polypeptides in this region is proteolysis prior
to electrophoresis in the second dimension; but this is
unlikely because both normal and sickle membranes were
prepared in the presence of the proteolytic inhibitors, DFP
and EDTA, and were treated similarly during processing and
electrophoresis.
The most obvious protein alteration detected in sickle
membranes in the previously described electrophoretic
analysis was in protein band 4.1. Since protein band 4.1 is
Figure 11. Comparison of normal (A/A) and sickle (S/S)
membranes on two-dimensional (lEF/SDS-PAGE)
gels stained with coomassie blue. Note spots





a fundamental component of the membrane skeleton and
alterations in this protein have been shown to contribute to
the pathology of cells in other hemolytic anemias,
subsequent experiments were directed towards understanding
the mechanism for the increase in band 4.1b in sickle
membrane preparations.
In order to determine whether the increase in band 4.1b
of sickle membranes was due to proteolytic degradation
during membrane preparation, cells were washed and membranes
prepared in the presence of the proteolytic inhibitors, DFP
and PMSF. Qualitative analysis of membrane protein profiles
of gels stained with coomassie blue suggested that the
presence of the inhibitor, DFP (which is more potent than
PMSF) had no effect on the band 4.1b alteration (Fig. 12).
Furthermore, there was no quantitative difference in the
amount of protein 4.1b in between sickle membranes prepared
with or without inhibitors (Table I). This result suggests
that the alteration is not due to proteolysis during
processing of the blood.
Sickle whole cells were solubilized and analyzed on
SDS-polyacrylamide gels to determine whether the band 4.1
alteration was present after limited handling of the cells.
Although the whole cells contain more proteins in the band
4.1-4.5 region than membranes, the band 4.1 alteration was
readily detected in sickle cells (Fig. 13). This provides
further evidence that the band 4.1 alteration occurs in
The effect of the proteolytic inhibitor, DFP,
on band 4.1b f sickle membranes. Normal
(A/A) and sickle (S/S) membranes were
prepared in the presence and absence of 2 mM
DFP and subjected to SDS-polyacrylamide
Laemmli gel electroophresis followed by
staining with coomassie blue. Lanes (1)
normal membranes without DFP, (2) sickle
membranes without DFP, (3) normal membranes
with DFP and (4) sickle membranes with DFP.









QUANTITATION OF BAND 4.1a AND 4.1b OF NORMAL AND SICKLE
MEMBRANES IN THE PRESENCE AND ABSENCE OF PROTEOLYTIC
INHIBITORS
4.1a/3 4.lb/3
Normal 0.12 + .01 0.04 + .01
CONTROL
Sickle 0.10 + .02 0.09 + .02*
4.1a/3 4.lb/3
Normal 0.12 + .03 0.05 + .03
Sickle 0.11 + .03 0.10 + .03
4.1a/3 4.lb/3
Normal 0.12 + .02 0.04 + .02
Sickle 0.11 + .03 0.09 + .03
The amount of band 4.1a and band 4.1b with respect to band 3
was determined by densitometric analysis. The mean + SD was
determined from seven normal and sickle samples.
*p < 0.01
Figure 13. Comparison of normal (A/A) and sickle (S/S)
whole (intact) cell proteins on a SDS-
polyacrylamide Laemmli gel stained with
coomassie blue. Lanes (1) normal membranes,
(2) sickle membranes, (3) normal whole cells
and (4) sickle whole cells. The band 4.1b






vivo. However, it must be noted that the proteins in the
whole cell migrated at a slower rate than those in the
membranes. This may be attributed to the presence of a
greater concentration of proteins (primarily large
quantities of hemoglobin) in the whole cell preparation
which results in slight retardation of the mobility of
proteins. Protein band 4.1 was identified in this sample by
its relative mobility to band 3 as well as its
characteristic appearance as a doublet.
It has been suggested that sickle cell membranes
contain adsorbed cytoplasmic proteins which migrate in the
band 4.5 region (Riggs and Ingram, 1977). Therefore, it was
conceivable that the increase in band 4.1b in sickle
membranes was due to differential adsorption of a
cytoplasmic protein with the same molecular weight as
protein 4.1b. To test this possibility, the cytoplasmic
fraction from hypotonic lysis of sickle and normal cells was
subjected to electrophoresis. The proteins of the
cytoplasmic fraction migrated similarly to the proteins of
the whole cell (i.e., migrated at a slower rate than control
membrane proteins); thus, making it difficult to assess
whether a cytoplasmic protein of similar molecular weight to
band 4.1 might be responsible for the increased staining of
band 4.1b observed in sickle membrane protein profiles (Fig
14). However, there was no decrease in staining of sickle
cell cytoplasmic proteins in the band 4.1 region when
Figure 14. Comparison of cytoplasm from normal (A/A) and
sickle (S/S) cells on a SDS-polyacrylamide
Laemmli gel stained with coomassie blue.
Lanes (1) normal membranes, (2) sickle
membranes, (3) normal cytoplasm and (4)
sickle cytoplasm. Brackets indicate region
in which band 4.1b would be located.
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compared to normal cytoplasmic proteins suggesting that
adsorption of cytoplasmic proteins is not responsible for
the increased staining of band 4.1b of sickle membranes.
To provide further evidence that the band 4.1b
alteration is not due to the comigration of some other
protein, sickle membranes were extracted with Triton X-100
to partially purify band 4.1. Triton X-100, an anionic
detergent, is employed to extract membrane protein and lipid
components from the membrane skeleton. Protein 4.1
partitions with the membrane skeleton. Sickle membrane
skeletons possess the band 4.1 alteration characteristic of
sickle membranes (Pig. 15). In addition, the band 4.1a/4.1b
ratio in these skeletons is similar to that observed in the
membranes. This latter observation supports the hypothesis
that the increase in band 4.1b is due to an increase in the
amount of 4.1b polypeptide in sickle cell membranes.
Studies by Sauberman et al. (1979) suggest that an
increase in band 4.1b in certain pathologic erythrocytes is
due to an increased percentage of young cells (i.e.,
reticulocytes) in the blood. Therefore it was of interest
to determine whether the band 4.1 alteration was confined to
the reticulocyte-rich fraction of cells. Normal and sickle
cells were fractionated on 24% - 34% dextran gradients
followed by counting the number of reticulocytes in the top,
middle and bottom fractions. The reticulocytes were found
Figure 15. Partially-purified band 4.1 from normal (A/A)
and sickle (S/S) cells treated with Triton X-
100. Samples were electrophoresed on a SDS-
polyacrylamide Laemmli gel followed by
staining with coomassie blue. Lanes (1)
normal membranesr (2) sickle membranesr (3)
normal membrane skeleton and sickle membrane
skeletons. The band 4.1b alteration is




in higher percentages in the top fraction than in the other
fractions of the gradient (Table II).
Pyruvate kinase activity has been shown to decline as a
function of erythrocyte aging (Seaman et al., 1980).
Therefore, to confirm whether the dextran gradients were
fractionating the cells by age, an enzyme assay to measure
erythrocyte pyruvate kinase activity was performed on each
fraction. Normal cells from the top to the bottom fraction
showed a progressive decline in pyruvate kinase activity
(Fig. 16). Sickle cells also showed a decline in pyruvate
kinase activity, however, the overall activity for each
fraction was higher in these cells in contrast to the normal
cells. These results are consistent with the reticulocyte
counts.
Lux et al. (1979) have shown that irreversibly sickled
cells (ISCs) possess an uncharacterized defect in the
membrane skeleton which is responsible for the maintenance
of the altered shape characteristic of these cells. It was
therefore of interest to determine whether the band 4.1b
alteration was uniquely characteristic of the ISC-rich
fraction of cells. ISCs were found in high percentages in
the bottom fraction of dextran gradients (Table II).
Membranes from sickle cells were prepared from each
fraction, solubilized and subjected to electrophoresis to
determine whether the band 4.1 alteration was present in the
reticulocyte-rich top fraction, non-ISC-rich middle fraction
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TABLE II
PERCENTAGE OF RETICULOCYTES AND
IRREVERSIBLE SICKLED CELLS IN NORMAL AND SICKLE
BLOOD FRACTIONATED ON DEXTRAN GRADIENTS
FRACTION % RETICULOCYTES^ % ISCs^
Whole 1.1% +0.5 0
Top 7.8% + 5.2 0
Normal
Middle 2.0% + 3.0 0
Bottom 0% +0.2 0
Whole 10.2% +6.5 12.4% + 9.6
Top 18.7% + 7.2 9.0% + 4.7
Sickle
Middle 6.3% + 5.1 20.0% + 4.4
Bottom 0.5% + 0.1 71.5% + 6.0
^ A total of 1000 cells were counted to determine the
percentage of reticulocytes in each sample.
^ A total of 500 cells were counted to determine the
percentage of irreversible sickled cells in each sample.
The mean + SD was determined from data collected from four
experiments.
Figure 16. Histogram of pyruvate kinase activity in top,
middle and bottom fractions of dextran-
separate normal and sickle cells. Error bars













of ISC-rich bottom fraction. Qualitative analysis of gels
stained with coomassie blue showed that the band 4.1b
alteration is characteristic of all sickle erythrocytes
(Fig. 17). In addition, quantitative analysis via
densitometric scans revealed that the amount of band 4.1b
remained constant in all three fractions (Table III). This
suggests that the increase in band 4.1b is not unique to
either reticulocytes or ISC.
B. COMPARISON OF THE PROTEIN ORGANIZATION OF NORMAL AND
SICKLE MEMBRANES
As an approach to determine whether there is a
difference in the protein organization between sickle and
normal membranes, a variety of crosslinking reagents in
conjunction with SDS-PAGE was employed. The chemical
structures of the crosslinking reagents used in this study
are shown in Fig. 18.
Preliminary experiments were conducted to determine the
effective concentration and reaction times used for each
crosslinking reagent. In this study, the effects of one
concentration of each crosslinking reagent at one particular
time period on normal and sickle membranes are reported.
1. 0-phenathroline/copper sulfate
0-phenathroline/copper sulfate (0-phe) catalyzes the
oxidation of sulfhydryl groups leading to the formation of
disulfide bonds. Normal and sickle membranes were treated
Figure 17. Comparison of normal (A/A) and sickle (S/S),
membrane protein profiles of dextran-
fractionated cells on a SDS-polyacrylamide
Laemmli gel stained with coomassie blue.
Lanes (1) unfractionated normal membranes,
(2) normal membranes from the top fraction,
(3) middle fraction, (4) bottom fraction; (5)
unfractionated sickle membranes, (6) sickle
membranes from the top fraction, (70 middle
fraction and (8) bottom fraction. The band
4.1b alteration is indicated by the arrows.
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QUANTITATION OF THE AMOUNT OF BAND 4.1b IN MEMBRANES FROM
DEXTRAN-FRACTIONATED NORMAL AND SICKLE CELLS
Normal Sickle
Fraction 4.lb/3 4.lb/3
Control 0.07 + .01 0.12 + .01*
Top 0.08 + .01 0.12 + .01
Middle 0.08 + .01 0.13 + .01
Bottom 0.09 + .01 0.14 + .02
The amount of band 4.1b with respect to band 3 was
determined by densitometric analysis. The mean + SD
represent data from three individual experiments.
Statistical analysis was determined by the student t-test.
*p < 0.01
Figure 18. Chemical structures of crosslinking reagents,
(A) 0-phenanthroline/CuS04 (0-phe), (B)
Glutaraldehyde (Glute), (C) Dithiobis
(succinimidyl propionate) (DTSP), (D)
Dimethyl 3,3'-dithiobispropionimidate (DTBP)
and (E) Dimethyladipimidate. Cleavable sites
for disulfide reducing agents are indicated
by the arrows in DTSP and DTBP.
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with 3 mM 0-phe for 20 min (Fig. 19). Although some
crosslinked material did not enter the gel, crosslinked
products were observed between the top of the gel and above
the spectrin (bands 1 and 2) region and between spectrin and
band 3. These complexes have been designated 0-phe 1, 0-phe
2, 0-phe 3 and 3^ (which has been previously identified as
band 3 dimer by Steck, 1972). Several quantitative
differences were observed between the crosslinked sickle and
normal membrane sample. There is a decrease in staining
intensity in 0-phe 2, 0-phe 3, spectrin band 1, band 3 dimer
and band 5 (actin) of crosslinked sickle membranes. In
contrast, there is an increase in staining intensity at the
top of the gel and in band 6 of crosslinked sickle
membranes.
In an attempt to determine the components of the
crosslinked complexes, the samples were subjected to two-
dimensional diagonal gel electrophoresis (SDS-PAGE/SDS-PAGE)
followed by staining with coomassie blue (Fig. 20).
Although three high molecular weight complexes were visible
in the first dimension, only one was observed in the second
dimension. This was attributed to the inability of the
other two complexes to enter the gel as evidenced by
vertical streaking in the stacking gel at these regions
(data not shown). The complex that entered the gel appears
to be composed of spectrin (bands 1 and 2) and ankyrin (band
2.1).
Figure 19. Fairbanks SDS-polyacrylamide gels of normal
and sickle membranes crosslinked with 3 mM O-
phenanthroline for 20 min. Gels were stained
with coomassie blue. Gels (1) untreated
normal membranes, (2) untreated sickle
membranes, (3) crosslinked normal membranes
and (4) crosslinked sickle membranes.
Crosslinked products are designated 0-phe 1,
0-phe 2, 0-phe 3 and 3^.
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Figure 20. Analysis of the polypeptide composition of
normal and sickle membrane 0-phenanthroline-
induced crosslinked complexes by two-
dimensional diagonal gel electrophoresis.
Membranes were reacted with 3 mM 0-phe for 20
min. Gels were stained with coomassie blue.
The top panel (a) contains normal membrane
polypeptides, while the bottom panel (b)






A number of spots (proteins) in the normal membrane
preparation were observed off the diagonal including a
protein in the band 2.1 region, bands 3, 4.1, 5, 6 and 8 as
well as a few in the band 4.5 region. Sickle membrane
preparations had a similar pattern but most spots were not
as prominent as those observed in normal membrane
preparations. This suggests that these proteins are not as
reactive in sickle membranes as those in normal membranes
due to inaccessibility of sulfhydryl groups to the
crosslinking reagent.
2. Glutaraldehyde
Glutaraldehyde forms amide bridges between amino and
carbonyl groups of neighboring proteins. Membranes were
treated with 1 mM glutaraldehyde for 10 min, subjected to
electrophoresis followed by staining with coomassie blue.
Five crosslinked complexes were produced in both normal and
sickle membranes. They are designated as Glute 1, Glute 2,
Glute 3, Glute 4 and Glute 5 (Fig. 21). No differences were
observed in the crosslinked complexes produced in sickle
membranes when compared to normal membranes. Since gluta¬
raldehyde is an irreversible crosslinking reagent, the
components of the crosslinked products cannot be determined
by two-dimensional diagonal gel electrophoresis.
Fairbanks SDS-polyacrylamide gels o£ normal
and sickle membranes crosslinked with 1 itiM
glutaraldehyde for 10 min. Gels were stained
with coomassie blue. Gels (1) untreated
normal membranes, (2) untreated sickle
membranes, (3) crosslinked normal membranes
and (4) crosslinked sickle membranes.
Crosslinked products are designated Glute 1,















Dithiobis(succinimidylpropionate) (DTSP) is a cleavable
imidoester which specifically reacts with proteins by
amidination of primary amino groups. It can be cleaved with
disulfide reducing agents in the center of the molecule
(Fig. 22). Normal and sickle membranes were treated with 8
mM DTSP for 6 min. Some crosslinked material did not enter
the gel. However, four distinct crosslinked products: DS-
1, DS-2 and DS-3 were observed above the spectrin region in
both sickle and normal membranes in addition to band 3 dimer
(3^). No differences were observed between these two types
of membranes.
Although no differences were detected in the first
dimension, it was still of interest to determine the
components of the crosslinked complexes. Normal and sickle
membranes crosslinked with DTSP were subjected to two-
dimensional diagonal gel electrophoresis followed by
staining with silver (Fig. 23). The two types of membranes
had similar protein patterns. The three high molecular
weight complexes observed in the first dimension consist of
only spectrin bands 1 and 2 in both sickle and normal
membrane preparations. Bands 3, 4.1, 4.2, 4.9, 5, 6, 7 and
8 appeared as spots off the diagonal in both normal and
sickle membranes. Also, in the sickle membrane preparation,
a polypeptide to the right of the diagonal below band 4.2
Fairbanks SDS-polyacrylamide gels of normal
and sickle membranes crosslinked with 8 mM
DTSP for 6 min. Gels were stained with
coomassie blue. Gels (1) untreated normal
membranes, (2) untreated sickle membranes,
(3) crosslinked normal membranes and (4)
crosslinked sickle membranes. Crosslinked




Figure 23. Analysis of the polypeptide composition of
normal and sickle membrane DTSP-induced
crosslinked complexes by two-dimensional
diagonal gel electrophoresis. Membranes were
reacted with 8 mM DTSP for 6 min. Gels were
stained with silver. The top panel (a)
contains normal membrane polypeptides while





was detected. However/ the identity of this polypeptide is
unknown.
4. Dimethyl 3/3'-Dithiobispropionimidate
Dimethyl 3,3'-dithiobispropionate (DTBP) is also a
cleavable imidoester, similar to DTSP, however its
crosslinking kinetics is considerably slower. Sickle and
normal membranes treated with 15 mg/ml DTBP for 2 h produced
two crosslinked products designated DB-1 and DB-2 (Fig. 24).
The amount of DB-1 was similar in sickle and normal
membranes/ but DB-2 was reduced in sickle membranes relative
to normal.
Two-dimensional diagonal gels of normal and sickle
membrane crosslinked with DTBP revealed that DB-1 and DB-2
were composed of spectrin (Fig. 25). The only other
proteins which appear to have been crosslinked are bands
4.1/ 5/ 6 and 8. However/ relative small amounts of these
proteins were crosslinked/ possibly explaining why they were
not detected as crosslinked products in the first dimension.
5. Dimethyladipimidate
Dimethyladipimidate (DMA) is also an imidoester which/
like DTBP/ reacts with primary amino groups/ forming amide
linkages. When sickle and normal membranes are treated with
1 mM DMA for 20 min/ four crosslinked complexes are
produced; DM-1/ DM-2/ DM-3 and DM-4 (Fig. 26). There was a
decrease in staining intensity in all four crosslinked
Figure 24. Fairbanks SDS-polyacrylamide gels of normal
and sickle membranes crosslinked with 15
mg/ml DTBP for 2 h. Gels were stained with
coomassie blue. Gels (1) untreated normal
membranes, (2) untreated sickle membranes,
(3) crosslinked normal membranes and (4)
crosslinked sickle membranes. Crosslinked
products are designated DB-1 and DB-2
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Figure 25. Analysis of the polypeptide composition of
normal and sickle DTBP-induced crosslinked
complexes by two-dimensional diagonal gel
electrophoresis. Membranes were reacted with
15 mg/ml DTBP for 2 h. Gels were stained
with silver. The top panel (a) contains
normal membrane polypeptides while the bottom




Figure 26. Fairbanks SDS-polyacrylamide gel of normal
and sickle membranes crosslinked with 1 mM
DMA for 20 min. Gels were stained with
coomassie blue. Gels (1) untreated normal
membranes, (2) untreated sickle membranes,
(3) crosslinked normal membranes and (4)
crosslinked sickle membranes. Crosslinked





products in the sickle membrane preparation. However, since
DMA is a non-cleavable crosslinking reagent, samples could
not be subjected to two-dimensional diagonal gel analysis to
determine the components of the crosslinked products.
CHAPTER V
DISCUSSION
Sickle cell anemia is a disease with many complicating
features. Its two most common hematologic manifestations
are recurring painful crises (which are due to vaso-occlu-
sions) and chronic hemolysis. The primary etiologic factor
for the vaso-occlusion phenomenon is the polymerization of
the HbS molecule which leads to sickling. However, second¬
ary effects may contribute more directly to the pathogenesis
of the disease than does the sickling itself. These
secondary effects include abnormal cellular properties such
as decreased deformability (LaCelle, 1970), increased
adhesivity (Hebbel et al., 1980), alterations in the
asymmetric distribution of phospholipids (Chiu et al., 1979)
and increased intracellular calcium (Eaton et al., 1973),
all of which are presumably due to defects in the membrane
of the cell.
Many studies have been directed towards searching for a
defect(s) in the sickle cell membrane. One approach has
been to search for differences in protein composition
between sickle and normal membranes by employing SDS-
polyacrylamide gel electrophoresis. Durocher and Conrad
(1974) employed a discontinuous sulfate-borate polyacry¬
lamide gel electrophoresis system described by Neville
(1971) and observed no differences in the membrane protein
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profiles of normal and sickle erythrocytes, either visually
or by densitometry. Balias and Burka (1980) also failed to
demonstrate red cell membrane protein abnormalities in
sickle cells employing the phosphate buffer gel system of
Weber and Osborn (1969). However, in the most definitive
study, Riggs and Ingram (1977), employing the continuous
Tris-EDTA buffer system of Fairbanks (1971), reported
several statistically significant alterations in the protein
profile of sickle cell membranes including an increase in
bands 4, 5, 6, 7 and 8, a decrease in band 3 and a reduction
in glycoproteins, PAS 1, 2 and 3. These conflicting reports
appear to be due to the different types of gel systems used
in each study as well as the inability of the particular gel
system to resolve minor differences between normal and
sickle membrane protein profiles.
In an attempt to search for and characterize additional
differences in the protein composition of sickle membranes,
the discontinuous Tris-glycine buffer system of Laemmli
(1970) was employed in this study. The Laemmli gel system
has been shown to improve the resolution of polypeptides
between the molecular weight range of 40,000 to 80,000. In
addition, 5-15% polyacrylamide linear gradient gels as
opposed to 10% polyacrylamide isotropic gels were employed
to further improve the resolution of proteins in both the
high and low molecular weight regions. The combination of
these two properties provided the most highly resolving one-
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dimensional SDS-polyacrylamide gel system available for this
study.
To further extend the capabilities of this gel system
to resolve minor differences between normal and sickle
membrane protein profiles, a variety of stains (i.e.,
coomassie blue, silver, gelcode and kodavue) were employed.
Coomassie blue, the most commonly used protein stain, is
relatively simple and inexpensive to use. This stain was
capable of detecting an increase in band 4.1b, an increase
in the amount of polypeptides found in the band 4.5 region
and an increase in the globin band. However, the fact that
coomassie blue stains only certain classes of proteins
(Dzandu et al., 1984) and is unable to detect proteins in
low or trace concentrations (Merril et al., 1980) warranted
the use of other stains to attempt to detect additional
differences.
Silver has been reported to be 100-200 times more
sensitive than coomassie blue (Merril et al., 1980; Sammons
et al., 1981). In contrast to coomassie blue, which stains
proteins by adsorption and selective desorption of the dye,
silver stains proteins based on a photographic process
called amplification (Yudelson, 1984). This involves the
depositing of the metal on the surface of the gel in
regions where proteins are present, thus enhancing
visualization of these proteins. Silver stain can detect as
little as 0.1 ng protein/mm^ gel and is also capable of
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producing a variety of colors which aid in identifying and
characterizing different classes of proteins (Merril et al.,
1982; Ochs et al., 1981; and Sammons et al., 1981).
There are several silver staining methods available,
which vary in sensitivity. Three silver staining methods
were employed in this study. The silver stain method of
Merril et al. (1980) was employed because it is a simple
method to use and can be purchased commercially from Bio-
Rad. This procedure resulted in the detection of a hmw
complex in sickle membranes; however this observation was
not reproducible due to overdevelopment of the stain in the
region of the gel above band 1. But this hmw complex could
be reproducibly demonstrated when the Bio-Rad stain was used
in conjunction with coomassie blue, a method developed by
Dzandu et al. (1984). The coomassie blue helps to displace
some of the excess silver ions which can interfere with the
staining process, thus allowing improved visualization of
polypeptides in the entire gel (Dzandu, personal
communication).
The second silver staining method employed was that of
Tsang et al. (1984). This method was used because its
sensitivity proved to be superior to other methods. This
method made detection of minor proteins easier to visualize
because most proteins were darkly stained in contrast to the
silver staining methods of Merril et al. (1980) and gelcode
(Sammons et al., 1980). This may be attributed to the
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utilization of additional fixation and washing steps
involving glutaraldehyde and dithiothreitol, both of which
enhance staining.
Gelcode (a modified silver staining procedure) is
reported to be a very sensitive silver stain and can stain
proteins in a range of colors from yellow, red and green
(Sammons et al., 1980); however, in this study, most of the
proteins in both normal and sickle membranes were stained
yellow. Some differences such as the protein in the band
4.5 region and the absence of a protein in the band 5 & 6
region were detected employing this stain.
Kodavue is another staining procedure that works on the
principle of amplification. It requires the use of the
metal, nickel, and is reported to be 50-100 times more
sensitive than coomassie blue (Yudelson, 1984). The
staining procedure and utilizes more stable reagents than
does silver or gelcode. However, in this study this
procedure did not prove to be any more sensitive than
coomassie blue; thus, its use did not result in the
detection of additional differences between normal and
sickle membranes.
There are technical reasons which may explain the low
sensitivity of kodavue exhibited in this study which is
contradictory to reports indicating that the stain is more
sensitive than coomassie blue. Nickel binds to the surface
of the gel and therefore, is more susceptible to surface
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contaminants. When precautions were taken to insure that
extremely clean glass plates (i.e., absent of organic
surfactants) were used, the sensitivity of the stain
improved. Also, it is critical that highly purified water
(e.g., double distilled and deionized water) be used to
prepare gel and staining solutions. Pure grade water is also
required for extensive washing during the staining procedure
to remove impurities from the surface of the gel which can
interfere with the staining process.
In general, the silver staining methods employed here
have revealed that there are many minor red cell membrane
proteins which have gone undetected using coomassie blue.
This suggests that the red cell membrane is more complex
than previously reported and that there are many more
proteins which remain to be characterized.
The most striking difference observed in comparing the
protein composition of sickle and normal membranes employing
SDS-PAGE was the two-fold increase in band 4.1b of sickle
membranes. Since sickle membrane preparations seem to be
more susceptible to proteolytic activity greater than normal
ones based on preliminary observations in this study, it was
conceivable that the increased staining in band 4.1 was due
to proteolysis of some other protein. However, DPP, the
most potent serine proteolytic inhibitor available, had no
effect on the staining intensity of band 4.1b, suggesting
that this alteration is not due to proteolysis during the
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preparation and solubilization of membranes. Intact sickle
erythrocytes, solubilized in sample buffer containing DFP,
also exhibited the alteration in band 4.1b. Therefore, the
alteration probably occurs iji vivo.
Studies by Allen and Cadman (1979) suggest that
proteins from the cytosol (cytoplasm) adsorb to human
erythrocyte membranes in the presence of calcium. Since
increased intracellular calcium has been found in sickle
cells (Eaton et al., 1973), it was conceivable that the
increase in band 4.1b in sickle membranes was due to
cytoplasmic adsorption. However, cytoplasmic adsorption of
a polypeptide with similar molecular weight as band 4.1b
does not appear to be responsible for this alteration since
no polypeptide in the region of band 4.1 of sickle cytoplasm
showed a reduction in staining intensity. However, the most
compelling argument against cytoplasmic adsorption is that
the band 4.1b alteration is present in sickle membrane
skeletons, whose preparation involves the partial
purification of protein 4.1. These findings support the
hypothesis that the band 4.1b alteration occurs in vivo.
It was conceivable that reticulocytes were responsible
for the increase in band 4.1b in cells of individuals with
sickle cell anemia, since it has been reported that
reticulocytes have a higher amount of band 4.1b than mature
cells (Sauberman et al., 1979) and because sickle cell
anemics typically have more reticulocytes in the peripheral
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circulation than normal individuals. However, when sickle
cells were separated on dextran gradients to obtain
fractions with varying concentrations of reticulocytes, and
their membranes analyzed on SDS-gels, no correlation was
observed between reticulocytes and the presence of the band
4.1b alteration since this alteration was characteristic in
all dextran fractions.
Investigators have studied the variations in band 4.1
levels in other hemolytic diseases. Sauberman et al. (1979)
described an increase in band 4.1b with respect to band 4.1a
in membranes of patients with hereditary xerocytosis, a
congenital hemolytic anemia associated with the appearance
of large, flat, dehydrated red cells. They also showed that
membranes from a normal individual with reticulocytosis
exhibited a similar increase in band 4.1b (Sauberman et al.,
1980). It was shown that this increase in band 4.1b
correlated with an increase in the percentage of
reticulocytes in the blood samples.
Alloisio et al. (1985) reported two classes of
hereditary elliptocytosis (HE) in which: (1) individuals
had a reduction in total band 4.1 as a result of a
significant decrease in band 4.1a but normal levels of band
4.1b; and (2) individuals had normal amounts of total 4.1
but the band 4.1a/4.1b ratio was reduced due to the
concomittant decrease in band 4.1a and increase in 4.1b.
This group attributed the reduction of the band 4.1a/4.1b
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ratio to the presence of young cells in both of these
conditions.
Mueller et al. (1987) have evaluated the change in the
band 4.1a/band 4.1b ratio in membranes as a function of mean
cell age in mice. They showed that band 4.1b levels were
higher in young erythrocytes but progressively declined with
the age of the cell until it reached approximately
equivalent amounts to band 4.1a.
A human model for erythrocyte age-dependent changes of
band 4.1 was observed in patients with transient
erythroblastopenia, a childhood disorder characterized by
temporary cessation of erythroid cell production
(Ravindranath et al., 1987). Studies of aged erythrocytes
circulating during marrow red cell aplasia, showed only the
'a' form of band 4.1 in these cells. When erythrocyte
production was resumed and the reticulocyte levels rose, the
predominate form was 4.1b. After recovery, the band
4.1a/4.1b ratio returned to normal.
The above studies suggest that an increase in band 4.1b
is attributed to the presence of young cells (i.e.
reticulocytes) in both hemolytic and normal states.
Although sickle cell anemia is characterized as a hemolytic
anemia and sickle cells are younger than normal ones, the
studies reported here suggest that the band 4.1b alteration
in sickle membranes is not due to the presence of younger
cells. Membranes from both unfractionated and dextran-
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fractionated sickle cells exhibit the band 4.1b alteration
which suggests that the alteration is not uniquely
associated with any particular population of cells. In
addition, there is no reduction in the amount of band 4.1a
in sickle cells when compared to normal cells.
Since sickle cell anemia is due to only one mutation
which affects the hemoglobin molecule, it is reasonable to
assume that the alteration in protein 4.1b occurs upon
sickling. The fact that all fractions of sickle cells
possess this alteration suggests that it occurs after the
cell sickles only a few times. An increase in the
concentration of this protein in the membrane could be due
to either an increased rate of synthesis or a decreased rate
of degradation. This latter mechanism is more likely, since
cell sickling probably does not begin until cells enter the
circulation, at a time when protein synthesis is essentially
shut off. It has been reported that sickle protein 4.1 is
oxidized (Rybicki et al., 1985). It is conceivable that
oxidation could lead to a conformational change in protein
4.1 which prevents its conversion to some other protein,
thereby resulting in its accumulation in the membrane.
Another interesting observation made in this study was
the appearance of the high molecular weight (hmw) complex in
sickle membranes. Studies have been directed towards
searching for such a complex in sickle cells to provide a
possible explanation for the decreased membrane
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deformability in these cells. A Ca'^’^-induced irreversible
polymer was observed in normal erythrocytes (Palek et al.,
1978, Siefring et al., 1978). This polymer has a
heterogeneous size distribution and is rich in gamma-
glutamyl-epsilon-lysine crosslinks. The formation of these
crosslinks is mediated by a normally dormant Ca'*'^-dependent
endogeneous red cell transglutaminase which catalyzes the
formation of covalent gamma-glutamyl-epsilon-lysine
crosslinks by means of an acyl transfer reaction in which
the gamma-carbamide group of peptide bound glutamine
residues are the acyl acceptors. Lorand and his colleagues
have proposed that the activation of transglutaminase may
lead to protein crosslinks which may have detrimental
effects on red cell properties (Lorand et al., 1976).
It has been well established that sickle cells have
elevated levels of Ca'*’^ in comparison to normal cells (Eaton
et al., 1973). Since the hmw complex detected in this study
could not be disrupted by chemicals which disrupt non-
covalent interactions, suggesting that it may be
irreversible, it is conceivable that it may be a polymer
with similar characteristics to the polymer observed by the
investigators cited above.
Another mechanism which may be responsible for the
formation of the high molecular weight complex is lipid
peroxidation. It has been shown that peroxidation of
polyunsaturated fatty acids of membrane lipids generate
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malonyldialdehyde (MDA), which can crosslink amino and
sulfhydryl containing molecules (Babior, 1981). It has also
been reported that sickle cells are more susceptible to
lipid peroxidation iji vitro (estimated by MDA generation) on
exposure of cells to exogeneous H2O2 (Chiu et al., 1982).
Therefore, it is conceivable that a hmw complex can form as
a result of oxidative stress to the membrane.
No significant differences were observed between sickle
and normal membranes employing isoelectric focusing (lEF)
and two-dimensional electrophoresis which have not been
previously reported or observed when employing one¬
dimensional SDS-polyacrylamide gel electrophoresis. In
general, the two-dimensional electrophoretic analysis
carried out here was not as resolving as theoretically
possible which may be attributed to artifactual charge
modification, aggregation of proteins due to incomplete
solubilization and poor focusing of certain proteins (e.g.,
band 3). Preliminary experiments showed that some of these
problems can be resolved by: 1) employing the detergent
CHAPS instead of NP-40; 2) focusing at higher voltages
(e.g., 400 volts for 10 hrs followed by 1000 volts for 2
hrs); 3) using glass tubes with a smaller diameter and 4)
employing DTT instead of 2-mercaptoethanol in solubilizing
buffers.
There are several methods available to study protein-
protein interactions (i.e. protein organization) in
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membranes. These include enzymatic, genetic and chemical
approaches (Steck, 1972; Wallach, 1972; Juliano, 1973; Zwaal
et al., 1973; Wang and Richards, 1974; Gaffney, 1985;
Rybicki et al., 1985; and Manoil and Beckwith, 1986).
Chemical crosslinking was employed in this study due to its
relative simplicity and high degree of resolution when
compared to other methods. A variety of crosslinking
reagents with different reactivities were chosen to gain a
better assessment of the various types of crosslinked
complexes produced when comparing sickle and normal
membranes.
The crosslinking data from this study shows that
similar crosslinked products are formed when comparing
sickle and normal membranes and that these results are
reproducible. This suggests that the crosslinking is not
random.
A number of observations made in this study were also
observed by other investigators. Of all the membrane
components, spectrin (bands 1 and 2) is the most rapidly
crosslinked protein by 0-phe and DTBP (Wang and Richards,
1974). Band 3 is the next most readily crosslinked protein
(Steck, 1972; Wang & Richards, 1974). Steck (1972)
concluded that this protein is a dimer based on detection
and reversal of dimer complexes from membranes crosslinked
with 0-phe. When band 4.1 is crosslinked with 0-phe and
DTBP, it is shifted upwards in the band 3 region. Band 5,
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in contrast, is shifted to the band 6 position after
crosslinking with 0-phe. This supports the view that the
complexes detected in this study are legitimate membrane
protein complexes.
The general finding from the work with crosslinking
reagents is that a smaller amount of crosslinked product is
formed in sickle membranes than in normal ones. The reduced
amount of crosslinked products produced could be due to a
difference in the organization of crosslinked proteins in
the membrane or a change in the chemistry of these proteins,
so that they are no longer as reactive with the crosslinking
reagent. 0-phe reacts differently than either DMA or DTBP,
yet similar results are seen with all three reagents, which
suggests that the reason for the reduced reactivity in
sickle membrane proteins is a difference in organization.
Since spectrin is the major component of the crosslinked
complexes detected in this study, it is reasonable to
conclude that spectrin molecules are more closely associated
in normal membranes than in sickle ones. This difference
may account for the reduced deformability characteristic of
sickle cells.
In conclusion, several alterations were detected in
sickle membranes employing various high resolution
electrophoretic techniques. Experiments have been carried
out to clarify the mechanism of the alteration in protein
4.1b, but further study is warranted to understand the
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mechanism involved in producing this and the other
alterations detected. Clarification of mechanisms could
lead to determining whether these molecular alterations are
a cause of the cellular abnormalitites in sickle cells.
Ultimately, this approach may lead to a therapeutic
treatment for sickle cell anemia.
Chapter VI
SUMMARY
The following conclusions were reached based on the
data obtained in this study:
1. Several differences in protein composition were
detected between. normal and sickle membranes employing
coomassie blue, silver and gelcode stains.
2. There is a two-fold increase in band 4.1b in
sickle membranes when compared to normal membranes.
3. The protein 4.1 alteration in sickle membranes is
not due to proteolysis occurring during processing of the
blood since it appears in membrane preparations in the
presence of a potent protease inhibitor, diisopropylfluoro-
phosphate (DFP).
4. This alteration is characteristic of the whole
cell of sickle cells suggesting that the alteration occurs
in vivo.
5. The alteration is not due to differential
adsorption of a cytoplasmic protein since there is not a
reduction in a band in the 4.1 region in sickle cytoplasm,
and the alteration is characteristic of protein 4.1 in
sickle membrane skeletons, in which the protein is partially
purified.
6. The protein 4.1b alteration is not uniquely
associated with either the youngest cells in the population
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(top fraction) or the irreversible sickle cell population
(bottom fraction) since it is present in all fractions of
dextran-separated sickle cells.
7. A high molecular weight (hmw) protein complex was
detected in sickle membranes which could not be disrupted by
protein pertubants: DTT, urea or 2-mercaptoethanol.
8. No significant differences in protein composition
between sickle and normal membranes were observed employing
isoelectric focusing and two-dimensional gel
electrophoresis.
9. Quantitative differences were detected in protein
complexes after treatment of sickle membranes with the
crosslinking reagents: 0-phenanthroline, DTBP and DMA. This
suggests that there is a difference in protein organization
between sickle and normal membranes.
It is clear from this study that there are several
molecular alterations in the sickle membrane. Although, the
mechanism(s) responsible for these alterations is unclear,
it is conceivable that these alterations are a cause of the






PREPARATION OF DEXTRAN 40 SOLUTIONS
1. Prepare suspension medium containing 0.585M KH2PO4, 3.141
M NaH2P04*H20, 8.6M glucose, 6.277M NaCl, 0.096M MgS04, pH
7.4.
2. Prepare Dextran 40 solutions as follows:


























0-phe 500 25 125
Glute 500 250 125
DTSP 500 100 100
DTBP 500 250 250*
DMA 500 125 250
*Add 25 ul NH3AC prior to solubilizing sample
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APPENDIX C
Solutions for Fairbanks SDS-Polyacrylamide Gel Electrophoresis
A. lOX Tris-Acetate Buffer, pH 7.4
1. Prepare IM Tris, 1000 mis
2. Prepare 2M sodium acetate (NaAc), 500 mis
3. Prepare 0.2M EDTA, 500 mis
4. Add ingredients as described below;
Components 1 L 2 L 4 L
IM TRIS 400 ml 800 ml 1600 ml
2M NaAc 100 ml 200 ml 400 ml
0.2M EDTA 100 ml 200 ml 400 ml
dH20 (Adjust to final volume after
pH'ing solution to 7.4 with
glacial acetic acid).
B. 4% Fairbanks gel solution
Components 40 mis 80 mis 120 mis
Acrylamide Stock* 5. 33 ml 10. 66 ml 16. 04 ml
10 X Tris-Acetate 4. 00 ml 8. 00 ml 12. 00 ml
20% SDS 0. 40 ml 0. 80 ml 1. 20 ml
dH20 29. 66 ml 59. 32 ml 89. 00 ml
100% TEMED 0. 02 ml 0. 04 ml 0. 06 ml
10% A.P. 0. 40 ml 0. 80 ml 1. 20 ml
*Stock contains 30% acrylamide/0.8% bisacrylamide
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C. 4X Fairbanks Solubilizing Buffer
Components 50 mis
20% SDS 10 ml
lOX Tris-Acetate 2 ml
Sucrose 20 gm
1 mg/ml Pyronin Y 5 ml
dH20 adjust to final volume
D. Fairbanks Electrophoresis Buffer
Components 1 L 2 L 4 L
lOX Tris-Acetate 100 ml 200 ml 400 ml
20% SDS 50 ml 100 ml 200 ml
dH20 850 ml 1700 ml 3400 ml
103
APPENDIX D










after pH'ing solution to
8.3 with HCl)B.Laemmli Electrophoresis Buffer
Components 1 L
10 X Tris Glycine 100 ml









3580 mlC.4X Laemmli Sample Buffer
Components 50 mis
10% SDS 2.0 ml
IM Tris, pH 6.8 0.5 ml
Glycerol 20.0 ml
dH20 20.5 ml
0.5% Bromophenol blue 5.0 ml
2-mercaptoethanol 2.0 mlD.4.5% Quick Polymerizing Stacking Gel Solution
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Components 15 ml
Acrylamide Stock* 2.40 ml
1 M Tris-HCl, pH 6.8 2.00 ml
20% SDS 0.08 ml
dH20 10.88 ml
10% A.P. 0.09 ml
100% TEMED 0.04 ml
5-15% Laemmli Gradient Gel Solutions
To prepare two gels**:
5% Components 15%
5.0 ml Acrylamide Stock* 15.0 ml
6.0 ml 2 M Tris-HCl pH 8.8 6.0 ml
0.3 ml 10% SDS 0.3 ml
0.0 ml 60% Sucrose 8.7 ml
18.7 ml dH20 0.0 ml
4-17% Laemmli Gradient Gel Solutions
To prepare two gels**:
4% Components 17%
4.0 ml Acrylamide Stock* 17.0 ml
6.0 ml 2 M Tris-HCl pH 8.8 6.0 ml
0.3 ml 10% SDS 0.3 ml
0.0 ml 60% Sucrose 6.7 ml
19.7 ml dH20 0.0 ml
*Stock contains 30% acrylamide/0.8% bisacrylamide
**Pour each gel separately, adding 4 ul TEMED and 70 ul A.P
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APPENDIX E
SOLUTIONS FOR ISOELECTRIC FOCUSING
A. Treatment Buffer (0.0625 M Tris-Hcl, pH 6.8, 2% SDS, 10%
Glycerol, 5% 2-mercaptoethanol)
Components 100 ml
1 M Tris-HCl, pH 6.8 6.25 ml
20% SDS 10.00 ml
100% Glycerol 10.00 ml
100% 2-mercaptoethanol 5.00 ml
dH20 adjust to final volume
B. Sample Overlay Solution*
Components 100 ml
9 M Urea 11.0 g
pH 5-7 ampholytes 0.4 ml
pH 6-8 ampholytes 0.2 ml
dH20 adjust to final volume
C. Lysis Buffer*
Components 20 ml
9.5 M Urea 11.4 g
2.0% NP-40 4.0 ml
0.8% pH 5-7 ampholytes 0.4 ml
0.8% pH 6-8 ampholytes 0.4 ml
0.4% pH 3-10 ampholytes 0.2 ml




*Store in 1 ml aliquots at -20°C
D. lEF Gel Solution
Components 10 ml 20 ml 40 ml
Urea 5.5 g 11.00 g 22.00 g
30% Acrylamide Stock 1.66 ml 3.30 ml 6.64 ml
dH20 1.90 ml 3.80 ml 7.60 ml
10% NP-40 2.00 ml 4.00 ml 8.00 ml
pH 5-7 0.20 ml 0.40 ml 0.80 ml
pH 6-8 0.20 ml 0.40 ml 0.80 ml
pH 3-10 0.10 ml 0.20 ml 0.40 ml
100% TEMED** 7.5 ul 15 ul 30 ul
10% A.P.** 12.5 ul 25 ul 50 ul
**Add TEMED and A.P. after urea has dissolved in gel solution
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APPENDIX F
BIO-RAD SILVER STAIN PROCEDURE
(Purchase kit from Bio-Rad Laboratories)
1. Fix gels in 45% methanol/12% acetic acid.
2. Wash gels in 10% ethanol/5% HAc for 30 min.
3. Rinse gels several times in dH20 for 30 sec each.
4. Place gels in 200 ml of oxidizing solution for 20 min.
5. Wash gels several times in dH20 to remove yellow
background.
6. Stain gels with 200 ml of silver solution for 30 min.
7. Rinse gel twice with dH20 for 10 sec each.
8. Rinse gel once with developing solution for 5 s. Rinse
again (with agitation) for 1 min.
9. Develop gel in fresh developing solution to desired
staining intensity.10.Stop development with 5% HAc.
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APPENDIX G
SILVER STAIN PROCEDURE (Tsanq et al., 1984)
1. Fix gels in 200 mis of Fixative I (45% methanol/12% HAc)
for 30 min or overnight.
2. Wash gel 3X in 200 mis Fixative II (10% ethanol/5% HAc)
10 min each or IX for 30 min (not crucial).
3. Wash several times in dH20 for 10 sec each.
4. Wash IX in 200 mis 10% glutaraldehyde Fixative III for 30
min.
5. Wash several times in dH20 (3X, 10 min each).
6. Place gel in Reducer (10 ug/ml DTT) for 30 min.
7. Wash several times in dH20 - 30 secs each.
8. Stain with Silver (0.12 M AgN03) for 30 min.
9. Rinse once with dH20.
10. Rinse 2X (rapidly) with Developer (0.28 M Na2C03 in 0.02%
formaldehyde) then allow gel to further develop.
11. Rinse gel with dH20, then add stop bath (1% HAc) 5 min.
12. Reduce if necessary to clear background? wash lOX for 30
sec each with dH20.
*Farmer's Reducer:
Solution A; 37.5 g K3 Fe(CN)5 in 500 ml dH20
Solution B: 480 g Na2S203 in 2000 ml dH20
Working Solution: 2.5 ml Solution A
10.0 ml Solution B




(Purchase kit from Health Products, Inc., South Haven, MI)
1. Fix gels (0.5 mm thick) overnight in 50% ethanol/5% HAc.
2. Wash gels in 4 changes of dH20 for 15 min each.
3. Stain gels for 15 min with Silver solution (prepared
according to kit instructions).
4. Rinse gel once with dH20 for 5 s.
5. Reduce gel for 2 mm with Reducer solution (prepared
according to kit instructions).
6. Stabilize color in gel with 3 changes in stabilizer





(Purchase kit from Eastman Kodak Company, Rochester, NY)
1. Fix gels (0.5 mm thick) overnight in 50% methanol/10% HAc
or for 30 min in 300 ml 50% methanol.
2. Rinse gel in 300 ml of dH20 for 1-5 min.
3. Change to 300 ml of presensitizer for 1 min.
4. Repeat step 2.
5. Change to 300 ml of sensitizer for 1 min.
6. Repeat step 2.
7. Develop gel for 15-20 min in 300 ml of cooled (10°C)
developer solution.
8. Stop development and stabilize image in gel with 200 ml of
stabilizer solution for one hour.
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